Form EFFECT Checkpoint Therapeutics,
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | June 4, 2025 |
| Accession Number: | 0001104659-25-054632 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- ECA LNG Phase 1 Achieves First LNG Production
- Empresa Distribuidora de Electricidad de Mendoza S.A. (EDEMSA) Announces Early Tender Results of its Debt Tender Offer and Concurrent Consent Solicitation, and Election of Early Settlement
- SUBARU OF AMERICA ANNOUNCES PRICING ON 2027 SUBARU BRZ
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
